FDA Inspection 1029749 — Louise Charest, M.D.
The FDA completed an inspection of Louise Charest, M.D. on Sep 29, 2017 in Montreal. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 29, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Montreal (Canada)
Additional details
Clinical Investigator (CI)